Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
H&D Wireless Sweden Holding B | HDWB | Nov 21, 2024 | 0.00 | 0.00 |
H&M B | HMB | Nov 21, 2024 | 153.55 | +0.36 |
HAKI Safety A | HAKIA | Nov 21, 2024 | 27.00 | 0.00 |
HAKI Safety B | HAKIB | Nov 21, 2024 | 25.40 | -1.55 |
Hamlet BioPharma AB (publ) | HAMLETB | Nov 21, 2024 | 2.68 | -5.63 |
Hansa Biopharma | HNSA | Nov 21, 2024 | 29.88 | -2.35 |
Hanza AB | HANZA | Nov 21, 2024 | 65.55 | +0.15 |
Harm Reduction Group | NOHARM | Nov 21, 2024 | 0.05 | +4.00 |
Havsfrun Investment | HAVS | Nov 21, 2024 | 13.10 | +3.97 |
Havsfrun Investment B | HAVB | Nov 21, 2024 | 13.10 | +3.97 |
Haypp Group | HAYPP | Nov 21, 2024 | 59.80 | -2.29 |
Headsent | VIMAB | Nov 21, 2024 | 7.75 | -3.73 |
Heba B | HEBAB | Nov 21, 2024 | 30.60 | -0.65 |
Hedera Group | HEGR | Nov 21, 2024 | 2.50 | -4.58 |
Heimstaden Pref | HEIMPREF | Nov 21, 2024 | 14.46 | 0.00 |
Heliospectra | HELIO | Nov 21, 2024 | 0.49 | +12.05 |
Hemnet Group | HEM | Nov 21, 2024 | 321.00 | -0.25 |
Hemply Balance | HMPLY | Nov 21, 2024 | 0.04 | 0.00 |
Hernö Gin B | HERNOB | Nov 21, 2024 | 3.90 | -2.62 |
Hexagon B | HEXAB | Nov 21, 2024 | 91.12 | -1.19 |
Hexagon Purus | HPURO | Nov 21, 2024 | 4.92 | -4.19 |
Hexatronic Group | HTRO | Nov 21, 2024 | 36.45 | -0.74 |
Hexicon | HEXI | Nov 21, 2024 | 0.16 | +6.14 |
Hexpol B | HPOLB | Nov 21, 2024 | 106.10 | +1.92 |
Hifab B | HIFAB | Nov 21, 2024 | 3.12 | +0.65 |
High Coast Distillery B | HIGHCOB | Nov 21, 2024 | 41.20 | -4.19 |
Hilbert | HILBB | Nov 21, 2024 | 5.42 | +4.23 |
HMS Networks | HMS | Nov 21, 2024 | 374.80 | +0.92 |
Hoegh Autoliners ASA | HAUTOO | Nov 21, 2024 | 131.20 | -3.60 |
Hoi Publishing AB | HOIB | Nov 21, 2024 | 0.18 | +11.66 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.